Immunitybio is trading $7.74 (-4.03%) amid broad risk-off trading as hotter producer inflation pressures rate-cut expectations.
- S&P 500, Nasdaq, and Dow are each down more than 0.5%.
- Rising oil prices and heightened U.S.-Iran tensions are weighing on risk appetite.
- No fresh company-specific announcement was identified; the latest major update was a strong Q2 report published August 25.